Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 1
1973 2
1976 2
1977 1
1978 4
1979 1
1980 1
1981 3
1982 5
1983 5
1985 4
1986 1
1988 2
1989 1
1990 2
1991 5
1992 4
1993 5
1994 2
1995 2
1996 2
1997 2
1998 2
1999 2
2000 1
2001 1
2002 3
2003 2
2005 1
2006 3
2007 1
2008 3
2009 1
2010 8
2011 3
2012 2
2013 3
2014 4
2015 6
2016 12
2017 9
2018 7
2019 6
2020 4
2021 5
2022 5
2023 1

Text availability

Article attribute

Article type

Publication date

Search Results

143 results

Results by year

Filters applied: . Clear all
Page 1
Epidemiology and Pathophysiology of Multiple Sclerosis.
Ward M, Goldman MD. Ward M, et al. Among authors: goldman md. Continuum (Minneap Minn). 2022 Aug 1;28(4):988-1005. doi: 10.1212/CON.0000000000001136. Continuum (Minneap Minn). 2022. PMID: 35938654 Review.
Phase II study of ketogenic diets in relapsing multiple sclerosis: safety, tolerability and potential clinical benefits.
Brenton JN, Lehner-Gulotta D, Woolbright E, Banwell B, Bergqvist AGC, Chen S, Coleman R, Conaway M, Goldman MD. Brenton JN, et al. Among authors: goldman md. J Neurol Neurosurg Psychiatry. 2022 Jun;93(6):637-644. doi: 10.1136/jnnp-2022-329074. Epub 2022 Apr 13. J Neurol Neurosurg Psychiatry. 2022. PMID: 35418509 Free PMC article. Clinical Trial.
Phase 2 Trial of Ibudilast in Progressive Multiple Sclerosis.
Fox RJ, Coffey CS, Conwit R, Cudkowicz ME, Gleason T, Goodman A, Klawiter EC, Matsuda K, McGovern M, Naismith RT, Ashokkumar A, Barnes J, Ecklund D, Klingner E, Koepp M, Long JD, Natarajan S, Thornell B, Yankey J, Bermel RA, Debbins JP, Huang X, Jagodnik P, Lowe MJ, Nakamura K, Narayanan S, Sakaie KE, Thoomukuntla B, Zhou X, Krieger S, Alvarez E, Apperson M, Bashir K, Cohen BA, Coyle PK, Delgado S, Dewitt LD, Flores A, Giesser BS, Goldman MD, Jubelt B, Lava N, Lynch SG, Moses H, Ontaneda D, Perumal JS, Racke M, Repovic P, Riley CS, Severson C, Shinnar S, Suski V, Weinstock-Guttman B, Yadav V, Zabeti A; NN102/SPRINT-MS Trial Investigators. Fox RJ, et al. Among authors: goldman md. N Engl J Med. 2018 Aug 30;379(9):846-855. doi: 10.1056/NEJMoa1803583. N Engl J Med. 2018. PMID: 30157388 Free PMC article. Clinical Trial.
Effect of natalizumab on disease progression in secondary progressive multiple sclerosis (ASCEND): a phase 3, randomised, double-blind, placebo-controlled trial with an open-label extension.
Kapoor R, Ho PR, Campbell N, Chang I, Deykin A, Forrestal F, Lucas N, Yu B, Arnold DL, Freedman MS, Goldman MD, Hartung HP, Havrdová EK, Jeffery D, Miller A, Sellebjerg F, Cadavid D, Mikol D, Steiner D; ASCEND investigators. Kapoor R, et al. Among authors: goldman md. Lancet Neurol. 2018 May;17(5):405-415. doi: 10.1016/S1474-4422(18)30069-3. Epub 2018 Mar 12. Lancet Neurol. 2018. PMID: 29545067 Clinical Trial.
Lung dysfunction in diabetes.
Goldman MD. Goldman MD. Diabetes Care. 2003 Jun;26(6):1915-8. doi: 10.2337/diacare.26.6.1915. Diabetes Care. 2003. PMID: 12766133 Review. No abstract available.
Statins to treat multiple sclerosis: friend or foe?
Goldman MD, Cohen JA. Goldman MD, et al. Neurology. 2008 Oct 28;71(18):1386-7. doi: 10.1212/01.wnl.0000327876.72639.e7. Neurology. 2008. PMID: 18955682 No abstract available.
Misdiagnosis of migraine.
Goldman MD, Login IS. Goldman MD, et al. Headache. 2003 Jan;43(1):85-6; author reply 86. doi: 10.1046/j.1526-4610.2003.03019.x. Headache. 2003. PMID: 12864768 No abstract available.
Clinical application of forced oscillation.
Goldman MD. Goldman MD. Pulm Pharmacol Ther. 2001;14(5):341-50. doi: 10.1006/pupt.2001.0310. Pulm Pharmacol Ther. 2001. PMID: 11603948 Review.
143 results